Proliferative Diabetic Retinopathy (PDR) Drug Pipeline Analysis and Therapeutic Assessment for H2 2017
All diabetic patients are at risk of developing eye diseases is called diabetic retinopathy. The longer the patient has diabetes and the more uncontrolled it is, the greater the risk. Proliferative diabetic retinopathy is an advanced form of diabetic eye disease. In recent years, growing incidence and prevalence of diabetes, growing cases of diabetes-associated blindness, rising geriatric population across the world has positively impacted the Proliferative Diabetic Retinopathy therapeutics market. To elaborate further about the effective treatments and clinical trials...
View full press release